Have done a great deal of research on the stats across the life...

Have done a great deal of research on the stats across the life of atl's data, my best guess is results will be +.5, or higher.

this would be an amazing victory for percheron as it solidifys all the clinical work / prior proof of efficacies to push avicuresen further towards approvals.

above +.5 can quite likely come from the 25mg dose or pulled up by the 50mg dose.

if the 50mg comes out worse than the 25mg we simply discover that 25mg, or lower is the sweet spot, and the 16 boy data helps with dosage analysis.

but if the 50mg comes out same or better, then the pul score is lifted higher, beyond the ph2a's result which is above +.889